Related Experiment Video
Updated: Jul 15, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Arterial stiffness alterations during hemodialysis: the role of dialysate calcium
John Kyriazis1, Irene Katsipi, Kostas Stylianou
1Department of Nephrology, General Hospital of Chios, Chios, Greece. jks@otenet.gr
Insights
High dialysate calcium (dCa) increases arterial stiffness (AS) during hemodialysis (HD), independent of blood pressure. Low dCa may reduce cardiovascular risk by preventing AS increases and hypercalcemia in HD patients.
Area of Science:
- Nephrology
- Cardiovascular Physiology
- Biomedical Engineering
Background:
- Dialysate calcium (dCa) levels are a key factor in hemodialysis (HD) prescription.
- Arterial stiffness (AS) is a significant predictor of cardiovascular risk.
- The impact of varying dCa on AS during HD is not fully understood.
Purpose of the Study:
- To investigate the influence of low (1.25 mmol/l) versus high (1.75 mmol/l) dCa concentrations on arterial stiffness (AS) during hemodialysis.
- To assess changes in stiffness index (SI) and reflection index (RI) as measures of AS.
- To determine if these changes are independent of blood pressure variations.
Main Methods:
- Fourteen HD patients participated in a randomized crossover study comparing low dCa (LdCa) and high dCa (HdCa) treatments.
- Arterial stiffness parameters (SI, RI) were measured using digital volume pulse (DVP) analysis before and during HD.
- Ionized serum calcium (iCa), blood pressure (BP), and heart rate (HR) were monitored throughout the study.
Main Results:
- High dCa (HdCa) significantly increased SI and RI by 5.7% and 6%, respectively.
- Low dCa (LdCa) did not alter SI or RI, and prevented the increase seen with HdCa.
- Serum ionized calcium (iCa) increased in the HdCa group and decreased in the LdCa group, with no significant differences in BP or HR between groups.
Conclusions:
- High dCa, but not low dCa, induces a significant, blood pressure-independent increase in arterial stiffness during hemodialysis.
- Low dCa hemodialysis may mitigate cardiovascular risk by preventing intradialytic increases in arterial stiffness and hypercalcemia.
- Optimizing dCa levels in HD prescriptions could be a strategy to reduce cardiovascular complications in patients.
Background/Aims:
We investigated the way dialysate calcium (dCa) level can influence arterial stiffness (AS), measured by stiffness index (SI), a surrogate of pulse wave velocity, and reflection index (RI), a measure of the amount of pulse wave reflection, derived by digital volume pulse (DVP).
Methods:
Fourteen hemodialysis (HD) patients underwent two consecutive midweek 4-hour HD treatments in randomized order with a low dCa concentration of 1.25 mmol/l (LdCa) and a high dCa concentration of 1.75 mmol/l (HdCa), respectively. Before HD and at 1-hour intervals during the subsequent 4-hour HD sessions, SI and RI measurements were obtained from DVP contour analysis. Blood pressure (BP) and heart rate (HR) were measured after each measurement of AS. Ionized serum calcium (iCa) was measured before HD and at 120 and 240 min into the HD session.
Results:
iCa increased and decreased by 15.3 and 5.4% in the HdCa and LdCa groups, respectively, at the end of HD. SI and RI increased by 5.7 and 6% in the HdCa group, respectively, whereas they remained unchanged in the LdCa group. The treatment effect and the time x treatment effect were significant for both indices (ANOVA). BP and HR changes did not differ between treatments.
Conclusion:
Contrary to LdCa, HdCa treatment induced a BP-independent, significant increase in measured AS parameters. In the long run, HD with LdCa, by reducing the incidence of HD-induced hypercalcemia, may have a beneficial role in minimizing the cardiovascular risk related to the intermittent, intradialytic increase in AS, inherent in the chronic use of HdCa.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Skeleton and Calcium Homeostasis
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
